Acute Telogen Effluvium: A Sequela of COVID-19 Infection

    Tejas kant, Upma Narain, Arun Kant
    Studysummary This study found that 74.6% of COVID-19 patients in Prayagraj experienced telogen effluvium hair loss, predominantly affecting females.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results